Glucagons and Glucagon-Like Peptides (GLP-1 / GLP-2)

Liraglutide

[Price Inquiry]
CAT#
10-101-59
Synonyms/Alias
NN2211; Victoza; D06404
CAS No.
204656-20-2
Sequence
HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutamyl] EFI AWLVRGRG
M.W/Mr.
3751.2
Molecular Formula
C172H265N43O51
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Marketed under the brand name Victoza, liraglutide is an injectable drug developed for the treatment of type 2 diabetes.
Description
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion.
Areas of Interest
Diabetes II
Home | Site Map | Contact Us | Resources
Copyright © 2008 - 2016 Creative Peptides. All rights reserved.